業績（2022年）

(1) 原著:

1) Nogami T, Arakawa R, Sakayori T, Ikeda Y, Okubo Y, TatenoA: Effect of DL-Methylephedrine on Dopamine Transporter Using Positron Emission Tomography With [18F]FE-PE2I. Front. Psychiatry, 31:799319. May 2022

2) Katayama K, Morimura N, Kobayashi K, Corbett D, Okamoto T, Ornthanalai V, Matsunaga H, Fujita W, Matsumoto Y, Akagi T, Hashikawa T, Yamada K, Murphy N, Nagao S, Aruga J: Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation. iScience 25: 104604 (2022)

3) Park J, Kim J, Mikami T: Exercise hormone irisin prevents physical inactivity-induced cognitive decline in mice. Behavioural Brain Research 2022 Jul 15;433:114008.

4) Kobayashi K, Shikano K, Kuroiwa M, Horikawa M, Ito W, Nishi A, Segi-Nishida A, Suzuki H: Noradrenaline activation of hippocampal dopamine D1 receptors promotes antidepressant effects. Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2117903119.

5) Takada H, Osada Y, akajima M, Sakai A, Hoshi T, Hama T, Koyama T, Suzuki H, Ogawa R: Does noncontact phased-array ultrasound promote hair regrowth? Journal of Dermatological Science 108 (2022) 51–54.

6) Ikeda Y, Funayama T, Okubo Y, Suzuki H: The role of left insula mediating impaired error processing in response inhibition in adult heavy drinkers. Cerebral Cortex, in press.

7) Ikuma Y, Sakai A, Sakamoto A, Suzuki H: Increased extracellular release of microRNAs from dorsal root ganglion cells in a rat model of neuropathic pain caused by peripheral nerve injury. PLoS ONE 18(1): e0280425.

(2) 総論

丸山基世、鈴木秀典、坂井敦：細胞外非コードRNAの疼痛疾患治療への応用可能性．PAIN RESEARCH Vol.37, No.2, p89-96 (2022)(令和4年7月15日発行)

(3)著書

鈴木秀典、齋藤文仁（分担執筆）：自閉スペクトラム症とセロトニン．Annual Review 神経2022、p84-92、2022年5月25日発行、中外医学社